Orthofix enters enhanced severance agreements with CEO, CFO, and three other officers

Orthofix Medical Inc.

CEO Valentine gets 1.5x salary+target bonus severance (2.99x in CiC period through Jan 2025); other executives get 1.0x (1.5x in CiC).
SeaSpine merger (Jan 5, 2023) triggers CiC period running through Jan 4, 2025 for all agreements.
COBRA reimbursement: up to 18 months for CEO; up to 12 months for other executives; equity awards get partial/full acceleration.
Agreements supersede prior employment agreements (Valentine), SeaSpine retention plan (Bostjancic, Keran), and prior severance deals (Elting, Kenny).
No minimum compensation guaranteed; benefits conditioned on signing release and compliance with non-compete/solicitation covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.